Li Lei, He Haisheng, Jiang Sifang, Qi Jianping, Lu Yi, Ding Ning, Lin Hai-Shu, Wu Wei, Xiang Xiaoqiang
Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai 201203, China.
Key Laboratory of Smart Drug Delivery of MOE and PLA, School of Pharmacy, Fudan University, Shanghai 201203, China.
Molecules. 2021 Feb 26;26(5):1271. doi: 10.3390/molecules26051271.
The application of physiologically based pharmacokinetic models to nanoparticles is still very restricted and challenging, owing to the complicated in vivo transport mechanisms involving nanoparticles, including phagocytosis, enhanced permeability and retention effects, cellular recognition, and internalisation, enzymatic degradation, lymphatic transport, and changes in physical properties. In our study, five nanoparticle formulations were synthesised using polycaprolactone as a framework material and methoxy poly (ethylene glycol)-poly(ε-caprolactone) as a long-circulating decorating material, as well as types of environmentally responsive near-infrared aza-boron-dipyrromethene dyes. According to quantification data and direct visualisation involving specific organs, a phagocytosis physiologically based pharmacokinetic model was developed to describe the dynamics of nanoparticles within and between organs in mice, considering cellular mechanisms involving phagocytosis and enhanced permeability and retention effects. Our results offer a better understanding of the in vivo fate of polymeric nanoparticles.
由于涉及纳米颗粒的体内转运机制复杂,包括吞噬作用、增强的渗透和滞留效应、细胞识别与内化、酶降解、淋巴转运以及物理性质的变化,基于生理的药代动力学模型在纳米颗粒上的应用仍然非常有限且具有挑战性。在我们的研究中,使用聚己内酯作为骨架材料、甲氧基聚(乙二醇)-聚(ε-己内酯)作为长循环修饰材料以及环境响应型近红外氮杂硼二吡咯亚甲基染料合成了五种纳米颗粒制剂。根据定量数据和涉及特定器官的直接可视化结果,考虑到涉及吞噬作用以及增强的渗透和滞留效应的细胞机制,建立了一个基于吞噬作用的生理药代动力学模型来描述纳米颗粒在小鼠体内器官内和器官间的动态变化。我们的结果有助于更好地理解聚合物纳米颗粒在体内的命运。